×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Cabaletta Bio Inc. (CABA) NASDAQ

$17.03 (0.12) (-0.70%)

Market Cap: $827.34M

As of 03/28/24 03:59 PM EDT. Market closed.

(CABA)

Cabaletta Bio Inc. (CABA)
NASDAQ

$17.03
(0.12) (-0.70%)

Market Cap: $827.34M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. ... read more

cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. the company's lead product candidate is dsg3-caart, which is in phase i clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and hemophilia a with factor viii alloantibodies. its product candidate pipeline also include musk-caart, a preclinical stage product to treat a subset of patients with myasthenia gravis; fviii-caart, a discovery stage product to treat a subset of patients with hemophilia a; and dsg3/1-caart, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. cabaletta bio, inc. has a collaboration with the un read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
66
Address
.
PRICE CHART FOR CABALETTA BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$17.14
Previous Close
$17.15
Days Range
$16.63 - $17.17
52 week range
$6.94 - $26.35
Volume
1,780,519
Avg. Volume (30 days)
1,064,086
Market Cap
$827.34M
Dividend Yield
-
P/E
-
Shares Outstanding
48,241,615
Open
$17.14
Previous Close
$17.15
Days Range
$16.63 - $17.17
52 week range
$6.94 - $26.35
Volume
1,780,519
Avg. Volume (30 days)
1,064,086
Market Cap
$827.34M
Dividend Yield
-
P/E
-
Shares Outstanding
48,241,615
FINANCIAL STATEMENTS FOR CABALETTA BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CABALETTA BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Binder GwendolynSee RemarksJan 19, 2024 Option Exercise$1.0111,00011,11031,000Jan 19, 2024, 06:30 PM
Binder GwendolynSee RemarksJan 19, 2024 Sale$19.5911,000215,43920,700Jan 19, 2024, 06:30 PM
Binder GwendolynSee RemarksDec 19, 2023 Option Exercise$1.0111,00011,11031,000Dec 19, 2023, 08:37 PM
Binder GwendolynSee RemarksDec 19, 2023 Sale$21.8911,000240,78923,132Dec 19, 2023, 08:37 PM
Binder GwendolynSee RemarksNov 20, 2023 Option Exercise$1.0111,00011,11031,000Nov 21, 2023, 04:30 PM
Binder GwendolynSee RemarksNov 20, 2023 Sale$17.8211,000196,01427,458Nov 21, 2023, 04:30 PM
Binder GwendolynSee RemarksOct 19, 2023 Option Exercise$1.0111,00011,11031,000Oct 19, 2023, 07:40 PM
Binder GwendolynSee RemarksOct 19, 2023 Sale$13.3611,000146,92120,408Oct 19, 2023, 07:40 PM
Binder GwendolynSee RemarksSep 19, 2023 Option Exercise$1.0111,00011,11031,000Sep 20, 2023, 04:30 PM
Binder GwendolynSee RemarksSep 19, 2023 Sale$17.5711,000193,22020,700Sep 20, 2023, 04:30 PM
Binder GwendolynSee RemarksAug 21, 2023 Option Exercise$1.0111,00011,11031,000Aug 22, 2023, 04:30 PM
Binder GwendolynSee RemarksAug 21, 2023 Sale$13.4211,000147,58320,300Aug 22, 2023, 04:30 PM
Binder GwendolynSee RemarksJul 19, 2023 Option Exercise$1.0111,00011,11031,000Jul 19, 2023, 08:37 PM
Binder GwendolynSee RemarksJul 19, 2023 Sale$13.8211,000152,02222,815Jul 19, 2023, 08:37 PM
Binder GwendolynSee RemarksJun 20, 2023 Option Exercise$1.0111,00011,11031,000Jun 21, 2023, 04:38 PM
Binder GwendolynSee RemarksJun 20, 2023 Sale$12.9911,000142,92520,000Jun 21, 2023, 04:38 PM
Binder GwendolynSee RemarksMay 19, 2023 Option Exercise$1.0122,00022,22042,000May 19, 2023, 08:10 PM
Binder GwendolynSee RemarksMay 19, 2023 Sale$11.8122,000259,83320,000May 19, 2023, 08:10 PM
Nichtberger StevenPresident & CEOOct 19, 2022 Buy$1.258,12710,152986,483Oct 19, 2022, 08:19 PM
Bollard CatherineDirectorOct 18, 2022 Buy$0.991,0009931,000Oct 18, 2022, 09:51 PM
Marda AnupChief Financial OfficerOct 18, 2022 Buy$0.9950,00049,62050,000Oct 18, 2022, 09:50 PM
Simon MarkDirectorOct 18, 2022 Buy$0.987,0006,8357,000Oct 18, 2022, 09:50 PM
Simon MarkDirectorOct 18, 2022 Buy$0.98118,000115,286136,144Oct 18, 2022, 09:50 PM
Binder GwendolynSee RemarksOct 18, 2022 Buy$0.9920,00019,89420,000Oct 18, 2022, 09:50 PM
Nichtberger StevenPresident & CEOOct 18, 2022 Buy$0.99141,873141,008978,356Oct 18, 2022, 09:50 PM
Nichtberger StevenPresident & CEOJan 31, 2022 Option Exercise$1.0150,00050,500836,483Feb 02, 2022, 04:26 PM
5AM Ventures V, L.P.10% OwnerNov 01, 2021 Sale$13.00295,0003,835,0001,731,119Nov 03, 2021, 04:38 PM
5AM Ventures V, L.P.10% OwnerSep 07, 2021 Sale$9.70625,0006,062,5001,989,575Sep 09, 2021, 05:34 PM
5AM Ventures V, L.P.10% OwnerJan 12, 2021 Sale$13.0085,0001,105,0002,614,575Jan 12, 2021, 05:07 PM
5AM Ventures V, L.P.10% OwnerJan 08, 2021 Sale$13.00302,0003,926,0002,689,045Jan 12, 2021, 05:07 PM
5AM Ventures V, L.P.10% OwnerDec 10, 2020 Sale$14.75298,0004,395,5002,953,634Dec 14, 2020, 05:58 PM
5AM Ventures V, L.P.10% OwnerOct 29, 2019 Buy$11.00454,5454,999,995454,545Oct 31, 2019, 06:03 PM
Flynn James E10% OwnerOct 29, 2019 Buy$11.00700,0007,700,000700,000Oct 30, 2019, 06:04 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Binder GwendolynSee Remarks01/19/202411,110
Binder GwendolynSee Remarks01/19/2024215,439
Binder GwendolynSee Remarks12/19/202311,110
Binder GwendolynSee Remarks12/19/2023240,789
Binder GwendolynSee Remarks11/20/202311,110
Binder GwendolynSee Remarks11/20/2023196,014
Binder GwendolynSee Remarks10/19/202311,110
Binder GwendolynSee Remarks10/19/2023146,921
Binder GwendolynSee Remarks09/19/202311,110
Binder GwendolynSee Remarks09/19/2023193,220
Binder GwendolynSee Remarks08/21/202311,110
Binder GwendolynSee Remarks08/21/2023147,583
Binder GwendolynSee Remarks07/19/202311,110
Binder GwendolynSee Remarks07/19/2023152,022
Binder GwendolynSee Remarks06/20/202311,110
Binder GwendolynSee Remarks06/20/2023142,925
Binder GwendolynSee Remarks05/19/202322,220
Binder GwendolynSee Remarks05/19/2023259,833
Nichtberger StevenPresident & CEO10/19/202210,152
Bollard CatherineDirector10/18/2022993
Marda AnupChief Financial Officer10/18/202249,620
Simon MarkDirector10/18/20226,835
Simon MarkDirector10/18/2022115,286
Binder GwendolynSee Remarks10/18/202219,894
Nichtberger StevenPresident & CEO10/18/2022141,008
Nichtberger StevenPresident & CEO01/31/202250,500
5AM Ventures V, L.P.10% Owner11/01/20213,835,000
5AM Ventures V, L.P.10% Owner09/07/20216,062,500
5AM Ventures V, L.P.10% Owner01/12/20211,105,000
5AM Ventures V, L.P.10% Owner01/08/20213,926,000
5AM Ventures V, L.P.10% Owner12/10/20204,395,500
5AM Ventures V, L.P.10% Owner10/29/20194,999,995
Flynn James E10% Owner10/29/20197,700,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CABALETTA BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.4,409,0050.00255%80.53%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.3,266,6450.15%No changeOther
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2,007,7290.84%-14.2%Other
HOLOCENE ADVISORS, LP1,920,3230.17%62.32%Growth At A Reasonable Price
BAKER BROS. ADVISORS LP13,3310.00344%-99.16%Other
GEODE CAPITAL MANAGEMENT, LLC753,1760.00179%8.86%Other
BLACKSTONE INC.347,4940.04%NewOther
UBS OCONNOR LLC48,3320.01%ExitedValue
AQR CAPITAL MANAGEMENT LLC13,7610.00059%-5.4%Other
CHANGE IN SHARES OUTSTANDING FOR CABALETTA BIO INC
STOCK BUYBACKS FOR CABALETTA BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
7.65%
1Q
12/31/2023
03/31/2023
36.72%
3Q
12/31/2023
12/31/2022
47.69%
4Q
12/31/2023
09/30/2022
47.69%
5Q
12/31/2023
06/30/2022
47.87%
6Q
12/31/2023
03/31/2022
47.87%
7Q
12/31/2023
12/31/2021
51.24%
8Q
12/31/2023
09/30/2021
71.58%
9Q
12/31/2023
06/30/2021
71.89%
10Q
12/31/2023
03/31/2021
78.07%
11Q
12/31/2023
12/31/2020
78.13%
12Q
12/31/2023
09/30/2020
78.25%
13Q
12/31/2023
06/30/2020
78.29%
14Q
12/31/2023
03/31/2020
78.29%
15Q
12/31/2023
12/31/2019
78.29%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
7.65%
1Q
03/31/2023
36.72%
3Q
12/31/2022
47.69%
4Q
09/30/2022
47.69%
5Q
06/30/2022
47.87%
6Q
03/31/2022
47.87%
7Q
12/31/2021
51.24%
8Q
09/30/2021
71.58%
9Q
06/30/2021
71.89%
10Q
03/31/2021
78.07%
11Q
12/31/2020
78.13%
12Q
09/30/2020
78.25%
13Q
06/30/2020
78.29%
14Q
03/31/2020
78.29%
15Q
12/31/2019
78.29%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CABALETTA BIO INC
LOADING...